Shukra Pharmaceuticals Ltd vs Vilin Bio Med Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 33.62 as of 06 May 15:30 . The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 37.1 on March 2021 to 99.3 on March 2025 . This represents a CAGR of 21.76% over 5 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 158.3 on March 2024 to 127.5 on March 2025 . This represents a CAGR of -10.25% over 2 years The Market Cap of Shukra Pharmaceuticals Ltd changed from ₹ 6.97 crore on March 2021 to ₹ 956.77 crore on March 2025 . This represents a CAGR of 167.62% over 5 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 26.51 crore on March 2024 to ₹ 28.46 crore on March 2025 . This represents a CAGR of 3.61% over 2 years The revenue of Shukra Pharmaceuticals Ltd for the Dec '25 is ₹ 39.95 crore as compare to the Sep '25 revenue of ₹ 7.59 crore. This represent the growth of 426.35% The revenue of Vilin Bio Med Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Shukra Pharmaceuticals Ltd for the Dec '25 is ₹ 27.95 crore as compare to the Sep '25 ebitda of ₹ 1.29 crore. This represent the growth of 2066% The ebitda of Vilin Bio Med Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Shukra Pharmaceuticals Ltd changed from ₹ 3.16 crore to ₹ 20.36 crore over 5 quarters. This represents a CAGR of 343.89% The net profit of Vilin Bio Med Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Shukra Pharmaceuticals Ltd changed from 10.47 % on March 2022 to 4.57 % on March 2025 . This represents a CAGR of -18.72% over 4 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

About Vilin Bio Med Ltd

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
The Company started its first commercial production in 2006.
In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

FAQs for the comparison of Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Shukra Pharmaceuticals Ltd or Vilin Bio Med Ltd?

Market cap of Shukra Pharmaceuticals Ltd is 1,472 Cr while Market cap of Vilin Bio Med Ltd is 68 Cr

What are the key factors driving the stock performance of Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd?

The stock performance of Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd?

As of May 6, 2026, the Shukra Pharmaceuticals Ltd stock price is INR ₹33.62. On the other hand, Vilin Bio Med Ltd stock price is INR ₹44.85.

How do dividend payouts of Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Shukra Pharmaceuticals Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.